Ubiquitin Immunohistochemistry Suggests Classic Motor Neuron Disease, Motor Neuron Disease With Dementia, and Frontotemporal Dementia of the Motor Neuron Disease Type Represent a Clinicopathologic Spectrum
暂无分享,去创建一个
[1] J. Trojanowski,et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease , 2004, Neurology.
[2] M. Mesulam,et al. Neuronal Ubiquitinated Intranuclear Inclusions in Familial and Non‐Familial Frontotemporal Dementia of the Motor Neuron Disease Type Associated with Amyotrophic Lateral Sclerosis , 2004, Journal of neuropathology and experimental neurology.
[3] H. Feldman,et al. Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study , 2004, Acta Neuropathologica.
[4] B. Miller,et al. Are amyotrophic lateral sclerosis patients cognitively normal? , 2003, Neurology.
[5] H. Feldman,et al. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases , 2003, Acta Neuropathologica.
[6] H. Feldman,et al. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease , 2003, Acta Neuropathologica.
[7] Catherine Lomen-Hoerth,et al. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.
[8] C. Duijn,et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval , 2002, Molecular Psychiatry.
[9] Odette A. Harris,et al. The role of hypothermia in the management of severe brain injury: a meta-analysis. , 2002, Archives of neurology.
[10] S. Al-Sarraj,et al. Ubiquitin‐only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neurone disease with dementia , 2002, Neuropathology and applied neurobiology.
[11] J. Trojanowski,et al. Update on the Neuropathological Diagnosis of Frontotemporal Dementias , 2001, Journal of neuropathology and experimental neurology.
[12] T. Iwaki,et al. Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum , 2001, Acta Neuropathologica.
[13] W. Kamphorst,et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. , 2001, Brain : a journal of neurology.
[14] D. Munoz,et al. Cognitive impairment in sporadic ALS , 2001, Neurology.
[15] Andrew Kertesz,et al. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions , 2001, Acta Neuropathologica.
[16] A. Kakita,et al. Ubiquitinated neuronal inclusions in the neostriatum in patients with amyotrophic lateral sclerosis with and without dementia--a study of 60 patients 31 to 87 years of age. , 2001, Clinical neuropathology.
[17] G. Leuba,et al. Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease , 2000, Acta Neuropathologica.
[18] Y. Yoshida,et al. Nigral degeneration in a case of amyotrophic lateral sclerosis: evidence of Lewy body-like and skein-like inclusions in the pigmented neurons. , 1999, Clinical neuropathology.
[19] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[20] J. Slade,et al. Amyotrophic Lateral Sclerosis Associated with Genetic Abnormalities in the Gene Encoding Cu/Zn Superoxide Dismutase: Molecular Pathology of Five New Cases, and Comparison with Previous Reports and 73 Sporadic Cases of ALS , 1998, Journal of neuropathology and experimental neurology.
[21] J. Lowe,et al. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. , 1998, Neuropathology and applied neurobiology.
[22] J. Lowe,et al. Motor neurone disease-inclusion dementia. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[23] P. Massman,et al. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[24] D. Mann,et al. τ Ubiquitin, and αB-Crystallin Immunohistochemistry Define the Principal Causes of Degenerative Frontotemporal Dementia , 1995 .
[25] N. Cairns,et al. Involvement of the amygdala, dentate and hippocampus in motor neuron disease , 1995, Journal of the Neurological Sciences.
[26] D. Neary,et al. Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[27] J. Lowe. New pathological findings in amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[28] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[29] R. Currier,et al. Decreased insulin-like growth factor I-mediated protein tyrosine phosphorylation in human olivopontocerebellar atrophy and lurcher mutant mouse , 1994, Journal of the Neurological Sciences.
[30] P N Leigh,et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. , 1993, Brain : a journal of neurology.
[31] S. Hirai,et al. Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease , 1992, Journal of Neurology.
[32] Bradley T. Hyman,et al. Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.
[33] D. Neary,et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia , 1992, Neuroscience Letters.
[34] Peter Davies,et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.
[35] H. Herzog,et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study , 1992, Acta neurologica Scandinavica.
[36] Yoichi Nakazato,et al. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis , 1991, Neuroscience Letters.
[37] M. Swash,et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. , 1991, Brain : a journal of neurology.
[38] D. Dickson,et al. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[39] D. Dickson,et al. UBIQUITIN IMMUNOREACTIVE STRUCTURES IN NORMAL BRAINS: DISTRIBUTION AND DEVELOPMENTAL ASPECTS , 1990 .
[40] A. Stracciari,et al. Cognitive impairment in motor neuron disease , 1985, Acta neurologica Scandinavica.
[41] A. Hudson. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. , 1981, Brain : a journal of neurology.
[42] A. Hirano,et al. Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. , 1967, Archives of neurology.
[43] I. Mackenzie. Senile plaques do not progressively accumulate with normal aging , 2004, Acta Neuropathologica.